Agenus
Agenus公司是一家致力于開發創新的免疫系統激活療法以治療癌癥和傳染性疾病的生物技術企業。
Agenus Inc. is a biotechnology company developing treatments for cancers and infectious diseases. The company has multiple immunotherapeutic products in its clinical development portfolio. Through partnerships involving its QS-21 Stimulon adjuvant, there are 21 candidates in clinical development. These include four late stage Phase 3 programs with GlaxoSmithKline.